Skip to content

Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals With Rheumatic Diseases.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05822219
Enrollment
60
Registered
2023-04-20
Start date
2024-03-15
Completion date
2027-12-31
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, COVID-19 Vaccine, Rheumatic Diseases, SLE

Keywords

Social network, Community based intervention, Vaccine uptake, Popular Opinion Leaders

Brief summary

To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.

Detailed description

Through community-academic partnerships in Boston and Chicago, investigators will recruit and randomly assign POLs who identify as Black with rheumatic conditions to two training arms in each city. Arms 1 and 2 will receive the same core curriculum addressing COVID-19 vaccine hesitancy, safety and efficacy. POLs will work in their communities to distributed information they learned in the trainings to members of their social network. The investigators will gather information about these social networks, assessing for differences in characteristics such as size, location, and who is in it (percentage of family, percentage Black, percentage with rheumatic conditions).

Interventions

BEHAVIORALCOVID-19 vaccine and booster training, and importance

COVID-19 vaccine and booster information training

Sponsors

Northwestern University
Lead SponsorOTHER
Brigham and Women's Hospital
CollaboratorOTHER
Boston Children's Hospital
CollaboratorOTHER
Boston Medical Center
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

Participants are unblinded but study has non-disclosure component of keeping the difference between the two training arms as non-disclosed until the conclusion of the study.

Intervention model description

Two different group training arms related to COVID-19 vaccine uptake

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

POLs: 18-85 years old; All genders; English-speaking; Self-identify as Black and/or African descent; Received ≥1 dose of a COVID-19 vaccine after 8.31.2022 (bivalent booster or updated COVID-19 vaccine \[2023-2024\] formula) Social network members: At least 18 years of age; All genders; English-speaking or Haitian Creole or Spanish-speaking if the POL also speaks Haitian Creole or Spanish; Not have received the updated COVID-19 vaccine 2023-2024 formula; Recent (within 3 months) COVID-19 infection and either undecided or no intention of receiving the vaccine.

Exclusion criteria

Both POLs and social network members: Under 18 years of age Pregnant women Institutionalized or incarcerated Those who are up to date on COVID vaccinations

Design outcomes

Primary

MeasureTime frameDescription
Receipt of >1 COVID-19 vaccine or booster dose6 monthsThis will be measured as documentation of receipt of \>1 additional COVID-19 vaccine or booster dose above network members' baseline number of doses, scored yes or no.

Secondary

MeasureTime frameDescription
Change in COVID-19 vaccine hesitancy6 monthsThis will be measured as the network members' absolute change in vaccine hesitancy scale score comparing 6 months to baseline between the two study arms, using the validated 10-item Likert Vaccine Hesitancy Scale, score range 10-50.
Structure and composition of the Popular Opinion Leader outreach networks.6 monthsA mixed methods social network assessment tool will be used to compare the structures and compositions of the outreach social networks of the Popular Opinion Leaders between the two intervention arms. This is not scored but rather used to create social network map and to understand characteristics of social networks.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRosalind Ramsey-Goldman, MD, DrPH

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026